Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Biomol Struct Dyn ; 42(6): 3051-3080, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-37203996

RESUMO

Citrus sinensis (L.) Osbeck (Rutaceae), commonly known as the sweet orange, is a popular and widely consumed fruit with several medicinal properties. The present study aimed to perform the in silico screening of 18 flavonoids and eight volatile components from the peel of C. sinensis against apoptotic and inflammatory proteins, metalloprotease, and tumor suppressor markers. Flavonoids obtained higher probabilities than volatile components against selected anti-cancer drug targets. Hence, the data from the binding energies against the essential apoptotic and cell proliferation proteins substantiate that they may be promising compounds in developing effective candidates to block cell growth, proliferation, and induced cell death by activating the apoptotic pathway. Further, the binding stability of the selected targets and the corresponding molecules were analyzed by 100 ns molecular dynamics (MD) simulations. Chlorogenic acid has the most binding affinity against the important anti-cancer targets iNOS, MMP-9, and p53. The congruent binding mode to different drug targets focused on cancer shown by chlorogenic acid suggests that it may be a compound with significant therapeutic potential. Moreover, the binding energy predictions indicated that the compound had stable electrostatic and van der Waal energies. Thus, our data reinforce the medicinal importance of flavonoids from C. sinensis and expand the need for more studies, seeking to optimize results and amplify the impacts of further in vitro and in vivo studies. Communicated by Ramaswamy H. Sarma.


Assuntos
Citrus sinensis , Flavonoides , Flavonoides/farmacologia , Flavonoides/química , Citrus sinensis/química , Simulação de Acoplamento Molecular , Ácido Clorogênico , Antioxidantes/química , Simulação de Dinâmica Molecular
2.
Chem Biol Drug Des ; 84(1): 116-22, 2014 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-24460654

RESUMO

Aspergillus flavus is a commonly found fungal pathogen which produces structurally related and highly toxic secondary metabolites, aflatoxins. It has been proposed that α-amylase inhibitors may limit the ability of the fungus to produce aflatoxins. Hence, this enzyme is a potent target for the development of antifungal agents. In this study, it was found that Spatholobus parviflorus seed lectin (SPL) can inhibit the growth of A. flavus with a MIC value of 1.5 mg/mL. The enzyme kinetics, molecular modeling and isothermal titration calorimetric studies suggest that SPL can inhibit α-amylase with Ki value of 0.0042 mm. Hence, it is suggested that the antifungal activity of SPL might be partly due to its ability to inhibit the enzyme α-amylase.


Assuntos
Antifúngicos/farmacologia , Aspergillus flavus/enzimologia , Fabaceae/química , Lectinas de Plantas/farmacologia , alfa-Amilases/antagonistas & inibidores , Antifúngicos/química , Antifúngicos/isolamento & purificação , Aspergilose/tratamento farmacológico , Aspergillus flavus/efeitos dos fármacos , Humanos , Cinética , Simulação de Acoplamento Molecular , Lectinas de Plantas/química , Lectinas de Plantas/isolamento & purificação , Termodinâmica , alfa-Amilases/química , alfa-Amilases/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...